Features Screener Stocks Charts
Sign In Sign Up

Pfizer Ltd. Cash Flow Statement

NSE:PFIZER | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.65x

PFIZER's operating cash flow covered 65% of net income in FY 2025. Some earnings may be tied up in working capital.

Free Cash Flow

₹6.32B

PFIZER's free cash flow was ₹6.32B in FY 2025, up 165.5% from FY 2024.

Dividend Coverage

3.9x

PFIZER's free cash flow covered dividends 3.9x in FY 2025, leaving room for reinvestment or debt reduction.

CapEx Intensity

4.3%

Capital expenditure was 4.3% of operating cash flow in FY 2025 for PFIZER, indicating a capital-light business.

2-year PFIZER cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 7.46B 10.16B
Cash flow Operating Activities 2.57B 6.60B
Investments in PPE -189.30M -281.50M
Cash flow Investing Activities 537.00M -713.40M
Dividend Paid -1.83B -1.60B
Cash flow Financing Activities -2.35B -2.05B
Cash at beginning of period 366.00M 1.12B
Cash at end of period 1.12B 4.95B
Free Cash Flow 2.38B 6.32B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025